<!DOCTYPE html>
<html>
<head>
<title>orsum result</title>
</head>
<body>

<details>
<summary>WP5087 Malignant pleural mesothelioma</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP5087 Malignant pleural mesothelioma (rank: 1, term size: 436)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	WP5087 Malignant pleural mesothelioma (rank: 1, term size: 436)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP5087 Malignant pleural mesothelioma (rank: 1, term size: 436)<br>
	<br>
	</p>
</details>

<details>
<summary>WP4298 Acute viral myocarditis</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4298 Acute viral myocarditis (rank: 2, term size: 85)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	WP4298 Acute viral myocarditis (rank: 9, term size: 85)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP4298 Acute viral myocarditis (rank: 5, term size: 85)<br>
	<br>
	</p>
</details>

<details>
<summary>WP4541 Hippo-Merlin signaling dysregulation</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4541 Hippo-Merlin signaling dysregulation (rank: 13, term size: 120)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	WP4541 Hippo-Merlin signaling dysregulation (rank: 2, term size: 120)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP4541 Hippo-Merlin signaling dysregulation (rank: 11, term size: 120)<br>
	<br>
	</p>
</details>

<details>
<summary>WP4673 Male infertility</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4673 Male infertility (rank: 16, term size: 145)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP4673 Male infertility (rank: 2, term size: 145)<br>
	<br>
	</p>
</details>

<details>
<summary>WP2447 Amyotrophic lateral sclerosis (ALS)</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP2447 Amyotrophic lateral sclerosis (ALS) (rank: 3, term size: 38)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	WP2447 Amyotrophic lateral sclerosis (ALS) (rank: 8, term size: 38)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP2447 Amyotrophic lateral sclerosis (ALS) (rank: 17, term size: 38)<br>
	<br>
	</p>
</details>

<details>
<summary>WP4577 Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway</summary>
	<p style="margin-left:40px">
	Overlap<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	WP4577 Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway (rank: 3, term size: 44)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	<br>
	</p>
</details>

<details>
<summary>WP2059 Alzheimer's disease and miRNA effects</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP2059 Alzheimer's disease and miRNA effects (rank: 8, term size: 275)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	WP2059 Alzheimer's disease and miRNA effects (rank: 11, term size: 275)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP2059 Alzheimer's disease and miRNA effects (rank: 3, term size: 275)<br>
	<br>
	</p>
</details>

<details>
<summary>WP5053 Development of ureteric collection system</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP5053 Development of ureteric collection system (rank: 4, term size: 60)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	WP5053 Development of ureteric collection system (rank: 4, term size: 60)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP5053 Development of ureteric collection system (rank: 13, term size: 60)<br>
	<br>
	</p>
</details>

<details>
<summary>WP5124 Alzheimer's disease</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP5124 Alzheimer's disease (rank: 6, term size: 262)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	WP5124 Alzheimer's disease (rank: 10, term size: 262)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP5124 Alzheimer's disease (rank: 4, term size: 262)<br>
	<br>
	</p>
</details>

<details>
<summary>WP4879 Overlap between signal transduction pathways contributing to LMNA laminopathies</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4879 Overlap between signal transduction pathways contributing to LMNA laminopathies (rank: 5, term size: 57)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	WP4879 Overlap between signal transduction pathways contributing to LMNA laminopathies (rank: 12, term size: 57)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP4879 Overlap between signal transduction pathways contributing to LMNA laminopathies (rank: 18, term size: 57)<br>
	<br>
	</p>
</details>

<details>
<summary>WP4540 Hippo signaling regulation pathways</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4540 Hippo signaling regulation pathways (rank: 24, term size: 98)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	WP4540 Hippo signaling regulation pathways (rank: 5, term size: 98)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP4540 Hippo signaling regulation pathways (rank: 20, term size: 98)<br>
	<br>
	</p>
</details>

<details>
<summary>WP3998 Prader-Willi and Angelman syndrome</summary>
	<p style="margin-left:40px">
	Overlap<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	WP3998 Prader-Willi and Angelman syndrome (rank: 6, term size: 68)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	<br>
	</p>
</details>

<details>
<summary>WP3584 MECP2 and associated Rett syndrome</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP3584 MECP2 and associated Rett syndrome (rank: 7, term size: 73)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	WP3584 MECP2 and associated Rett syndrome (rank: 19, term size: 73)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP3584 MECP2 and associated Rett syndrome (rank: 6, term size: 73)<br>
	<br>
	</p>
</details>

<details>
<summary>WP4549 Fragile X syndrome</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4549 Fragile X syndrome (rank: 14, term size: 112)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	WP4549 Fragile X syndrome (rank: 7, term size: 112)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP4549 Fragile X syndrome (rank: 8, term size: 112)<br>
	<br>
	</p>
</details>

<details>
<summary>WP4746 Thyroid hormones production and peripheral downstream signaling effects</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4746 Thyroid hormones production and peripheral downstream signaling effects (rank: 10, term size: 92)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP4746 Thyroid hormones production and peripheral downstream signaling effects (rank: 7, term size: 92)<br>
	<br>
	</p>
</details>

<details>
<summary>WP3995 Prion disease pathway</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP3995 Prion disease pathway (rank: 9, term size: 33)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	<br>
	</p>
</details>

<details>
<summary>WP5224 2q37 copy number variation syndrome</summary>
	<p style="margin-left:40px">
	Overlap<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP5224 2q37 copy number variation syndrome (rank: 9, term size: 168)<br>
	<br>
	</p>
</details>

<details>
<summary>WP4657 22q11.2 copy number variation syndrome</summary>
	<p style="margin-left:40px">
	Overlap<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP4657 22q11.2 copy number variation syndrome (rank: 10, term size: 149)<br>
	<br>
	</p>
</details>

<details>
<summary>WP4830 GDNF/RET signaling axis</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4830 GDNF/RET signaling axis (rank: 11, term size: 23)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	<br>
	</p>
</details>

<details>
<summary>WP4823 Genes controlling nephrogenesis</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4823 Genes controlling nephrogenesis (rank: 12, term size: 44)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	<br>
	</p>
</details>

<details>
<summary>WP4932 7q11.23 copy number variation syndrome</summary>
	<p style="margin-left:40px">
	Overlap<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP4932 7q11.23 copy number variation syndrome (rank: 12, term size: 113)<br>
	<br>
	</p>
</details>

<details>
<summary>WP4844 Influence of laminopathies on Wnt signaling</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4844 Influence of laminopathies on Wnt signaling (rank: 23, term size: 37)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	WP4844 Influence of laminopathies on Wnt signaling (rank: 13, term size: 37)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	<br>
	</p>
</details>

<details>
<summary>WP4906 3q29 copy number variation syndrome</summary>
	<p style="margin-left:40px">
	Overlap<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	WP4906 3q29 copy number variation syndrome (rank: 14, term size: 75)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP4906 3q29 copy number variation syndrome (rank: 19, term size: 75)<br>
	<br>
	</p>
</details>

<details>
<summary>WP4949 16p11.2 proximal deletion syndrome</summary>
	<p style="margin-left:40px">
	Overlap<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	WP4949 16p11.2 proximal deletion syndrome (rank: 15, term size: 81)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP4949 16p11.2 proximal deletion syndrome (rank: 14, term size: 81)<br>
	<br>
	</p>
</details>

<details>
<summary>WP4871 Kisspeptin/kisspeptin receptor system in the ovary</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4871 Kisspeptin/kisspeptin receptor system in the ovary (rank: 15, term size: 39)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	<br>
	</p>
</details>

<details>
<summary>WP5114 Nucleotide excision repair in xeroderma pigmentosum </summary>
	<p style="margin-left:40px">
	Overlap<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP5114 Nucleotide excision repair in xeroderma pigmentosum  (rank: 15, term size: 74)<br>
	<br>
	</p>
</details>

<details>
<summary>WP5120 Inclusion body myositis</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP5120 Inclusion body myositis (rank: 28, term size: 11)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	WP5120 Inclusion body myositis (rank: 16, term size: 11)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	<br>
	</p>
</details>

<details>
<summary>WP4312 Rett syndrome causing genes</summary>
	<p style="margin-left:40px">
	Overlap<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	WP4312 Rett syndrome causing genes (rank: 16, term size: 48)<br>
	<br>
	</p>
</details>

<details>
<summary>WP3853 ERK pathway in Huntington's disease</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP3853 ERK pathway in Huntington's disease (rank: 17, term size: 15)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	WP3853 ERK pathway in Huntington's disease (rank: 18, term size: 15)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	<br>
	</p>
</details>

<details>
<summary>WP4971 Phosphoinositides metabolism</summary>
	<p style="margin-left:40px">
	Overlap<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	WP4971 Phosphoinositides metabolism (rank: 17, term size: 49)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	<br>
	</p>
</details>

<details>
<summary>WP5102 Familial partial lipodystrophy</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP5102 Familial partial lipodystrophy (rank: 18, term size: 30)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	<br>
	</p>
</details>

<details>
<summary>WP4288 MTHFR deficiency</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4288 MTHFR deficiency (rank: 19, term size: 24)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	<br>
	</p>
</details>

<details>
<summary>WP5103 Progeria-associated lipodystrophy</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP5103 Progeria-associated lipodystrophy (rank: 20, term size: 22)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	<br>
	</p>
</details>

<details>
<summary>WP5269 Genetic causes of PSVD/INCPH</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP5269 Genetic causes of PSVD/INCPH (rank: 21, term size: 37)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	<br>
	</p>
</details>

<details>
<summary>WP5074 Kallmann syndrome</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP5074 Kallmann syndrome (rank: 22, term size: 24)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	<br>
	</p>
</details>

<details>
<summary>WP5110 Familial hyperlipidemia type 3</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP5110 Familial hyperlipidemia type 3 (rank: 25, term size: 13)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	<br>
	</p>
</details>

<details>
<summary>WP4224 Purine metabolism and related disorders</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4224 Purine metabolism and related disorders (rank: 26, term size: 22)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	<br>
	</p>
</details>

<details>
<summary>WP2371 Parkinson's disease pathway</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP2371 Parkinson's disease pathway (rank: 27, term size: 47)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AMI<br>
	<br>
	</p>
	<p style="margin-left:40px">
	RWR<br>
	<br>
	</p>
</details>
</body>
</html>
